FDA inspection

Beigene USA, Inc.: FDA inspection ending Apr 8, 2022

FDA inspection 1167967 · No Action Indicated (NAI) · San Mateo, CA

Key facts

Inspection ID 1167967
Firm Beigene USA, Inc.
FEI number 3014478572
Address 2955 Campus Dr
City San Mateo
State CA
ZIP 94403
Country United States
Fiscal year 2022
Inspection end date Apr 8, 2022
Classification No Action Indicated (NAI)
Project area Bioresearch Monitoring
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections